What are the evidence-based guidelines for the management and workup of salivary stones in adult patients?

Management and Workup of Salivary Stones in Adults

For adult patients with salivary stones, pursue minimally invasive, gland-preserving approaches as first-line therapy, with treatment selection based on stone location and size—endoscopy-assisted removal for distal/ductal stones and combined endoscopic-external approaches for proximal/hilar stones, reserving gland excision only for treatment failures.

Initial Diagnostic Workup

Clinical Assessment

Evaluate for these specific high-risk features that distinguish sialolithiasis from other pathology:

• Intermittent swelling of the affected gland, particularly with meals (pathognomonic for obstruction)
• Palpable stone along the duct course (bimanual palpation of floor of mouth for submandibular, buccal mucosa for parotid)
• Purulent discharge from the duct orifice
• Duration and pattern of symptoms (acute vs. chronic/recurrent)

Imaging Strategy

Order ultrasound as the first-line imaging modality for suspected sialolithiasis—it has replaced traditional sialography and avoids radiation 1. For complex cases or surgical planning, obtain CT with contrast or MR sialography 1. These cross-sectional studies are essential for:

• Precise stone localization (distal duct vs. proximal vs. hilar vs. intraglandular)
• Stone size measurement (critical for treatment selection)
• Assessment of gland parenchyma
• Surgical planning

Treatment Algorithm Based on Stone Characteristics

Stone Location Classification (Critical for Treatment Selection)

• Distal/ductal stones: Anterior portion of duct, accessible transorally
• Proximal stones: Posterior duct, less accessible
• Hilar stones: At gland hilum (≥15mm often classified as "giant")
• Intraglandular stones: Within gland parenchyma

Treatment Approach by Location

For Distal/Ductal Stones:

• Primary approach: Sialoendoscopy alone or with transoral sialolithotomy 2
• Success rate: 100% stone removal for distal submandibular stones 2
• This represents the highest success, lowest morbidity option

For Proximal/Hilar Stones:

• Primary approach: Combined endoscopic-assisted external approach 3
• Stone-free rate: 93% with symptom improvement in 91% 3
• Accept higher complication rate (24%) as trade-off for gland preservation 3
• This is superior to endoscopy alone for these locations

For Giant Stones (≥15mm):

• Primary approach: Combined approach (CA) using sialoendoscopy with external access 4
• Gland preservation: 86% vs. 57% with traditional approaches 4
• Traditional teaching recommended gland resection for hilar giant stones, but modern data supports preservation attempts first 4

For Multiple Stones:

• Expect multimodal therapy in 45% of cases 5
• Mean 2.55 interventions per patient required 5
• Stone-free/symptom-free status: 100% for submandibular, 97.6% for parotid 5
• Gland preservation: 97.2% overall 5

Adjunctive Therapies

Extracorporeal Shock Wave Lithotripsy (ESWL):

• Use as adjunct, not primary therapy 6, 3
• Stone-free rate only 58% 3
• Best role: fragmenting stones before endoscopic removal or for long-term symptom control 3

Laser Lithotripsy:

• Intracorporeal option during sialoendoscopy 6
• Use for stones too large for basket extraction but accessible endoscopically

When to Proceed to Gland Excision

Reserve submandibular/parotid gland resection for:

1. Failed gland-preserving attempts (occurs in ~3% with multimodal approach 6)
2. Intraglandular stones with persistent symptoms 2
3. Recurrent stones after multiple interventions with ongoing symptoms 7

Important Caveat About Gland Preservation

Gland preservation does NOT necessarily prevent xerostomia—xerostomia rates are comparable between preservation (27.3%) and resection (28.6%) at long-term follow-up 7. However, preservation carries 10% risk of requiring eventual gland removal for persistent symptoms 7.

Practical Management Pitfalls

Common Errors to Avoid:

• Ordering sialography (outdated, replaced by ultrasound/MR sialography) 1
• Proceeding directly to gland excision for hilar stones without attempting combined endoscopic approach 4
• Using ESWL as monotherapy (insufficient stone-free rates) 3
• Failing to counsel patients with multiple stones that they may need 2-3 procedures 5

Critical Success Factor: Stone location determines treatment modality more than stone size—distal stones have near-100% endoscopic success regardless of size, while proximal/hilar stones require combined approaches even when smaller 2.

Expected Outcomes

With modern multimodal, gland-preserving approaches:

• Overall gland preservation: 97% 5
• Stone-free/symptom-free status: >97% 5
• Ultimate surgical success (no additional interventions at 5-10 years): 91-100% 7
• No permanent facial nerve injuries reported with endoscopic approaches 3